Δημοσιεύσεις & Συνέδρια

Δημοσιεύσεις σε περιοδικά με κριτέs (Pubmed)

  1. Papadakis S, Anastasaki M, Gergianaki I, Koek G, Mendive J, Anastasiou F, Heyens L, Garcia-Retortillo M, Muris J, Lionis C. Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe. Front Med (Lausanne). 2023 Mar 23;10:1034626. doi: 10.3389/fmed.2023.1034626.
  2. Papastefanakis E, Dimitraki G, Ktistaki G, Fanouriakis A, Karamaouna P, Bardos A, Kallitsakis I, Adamichou C, Gergianaki I, Repa A, Bertsias G, Sidiropoulos P, Karademas E, Simos P. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample. 2021 Dec;30(14):2237-2247. PMID: 34861804.
  3. Gergianaki I, Garantziotis P, Adamichou C, Saridakis I, Spyrou G, Sidiropoulos P, Bertsias G. High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete. Journal of Clinical Medicine. 2021; 10(5):998. https://doi.org/10.3390/jcm10050998
  4. Tsiligianni I, Sifaki-Pistolla D, Gergianaki I, Kampouraki M, Papadokostakis P, Poulonirakis I, Gialamas I, Bempi V, Ierodiakonou D. Associations of sense of coherence and self-efficacy with health status and disease severity in COPD. NPJ Prim Care Respir Med. 2020 Jun 18;30(1):27. doi: 10.1038/s41533-020-0183-1
  5. Adamichou C, Nikolopoulos D, Genitsaridi I, Bortoluzzi A, Fanouriakis A,Papastefanakis E, Kalogiannaki E, Gergianaki I, Sidiropoulos P, Boumpas DT, Bertsias GK. In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment.  2020 Feb;79(2):232-241.  doi: 10.1136/annrheumdis-2019-216155. Epub 2019 Nov 8.
  6. Irini Gergianaki, Maria Kampouraki, Siân Williams, Ioanna Tsiligianni: Assessing spirituality: is there a beneficial role in the management of COPD?. npj Primary Care Respiratory Medicine 12/2019; 29(1)., DOI:10.1038/s41533-019-0134-x
  7. Panousis, Bertsias George, Halit Ongen, Irini Gergianaki, Maria G. Tektonidou, Maria Trachana, Luciana-Romano-Palumbo, Deborah Bielsier, Centric Howald, Cristina Pamfil, Antonis Fanouriakis, Despoina Kosmara, Argyro Repa, Prodromos Sidiropoulos, Emmanouil T Dermitzakis, Dimitrios T Boumpas: Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity Ann Rheum Dis. 2019 Aug; 78(8): 1079–1089. doi: 10.1136/annrheumdis-2018-214379
  8. Gergianaki I.,Tsiligianni, I. Chronic obstructive pulmonary disease and rheumatic diseases: A systematic review on a neglected comorbidity. J Comorb. 2019 doi: 10.1177/2235042X18820209
  9. Gergianaki I, Fanouriakis A, Adamichou C, Spyrou G, Mihalopoulos N, Kazadzis S, Chatzi L, Sidiropoulos P, Boumpas DT, Bertsias G Is systemic lupus erythematosus different in urban versus rural living environment? Data from the Cretan Lupus Epidemiology and Surveillance Registry. Lupus 2018 Dec 6 doi: 10.1177/0961203318816820
  10. Evangelos C Karademas, Georgia Dimitraki, Emmanouil Papastefanakis, Georgia Ktistaki, Argyro Repa, Irini Gergianaki, George Bertsias, Prodromos Sidiropoulos, Vasileios Mastorodemos, Panagiotis Simos: Emotion regulation contributes to the well-being of patients with autoimmune diseases through illness-related emotions: A prospective study. Journal of Health Psychology 07/2018; doi:10.1177/1359105318787010
  11. Irini Gergianaki, Alessandra Bortoluzzi George Bertsias Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus Best Practice and Research in Clinical Rheumatology 2018 DOI:  10.1016/j.berh.2018.09.004
  12. Irini Gergianaki, George Bertsias: Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner. 05/2018; 5., DOI:10.3389/fmed.2018.00161
  13. Antonis Fanouriakis, Ioannis Papalopoulos, Irini Gergianaki, Giorgis Spyrou, Abdulsamet Erden, Panagiota Rapsomaniki, Maria Terizaki, Nestor Avgoustidis, Argyro Repa, Nikolaos Kougkas, George Bertsias, Dimitrios T Boumpas, Prodromos I Sidiropoulos: In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study. Clinical and experimental rheumatology Sep-Oct 2018;36(5):806-813.
  14. Evangelos C. Karademas, Georgia Dimitraki, Emmanouil Papastefanakis, Georgia Ktistaki, Argyro Repa, Irini Gergianaki, George Bertsias, Prodromos Sidiropoulos, Panagiotis Simos: Adaptation to inflammatory rheumatic disease: Do illness representations predict patients’ physical functioning over time? A complex relationship. Journal of Behavioral Medicine 09/2017; 41(2)., DOI:10.1007/s10865-017-9889-0
  15. Irini Gergianaki, Antonis Fanouriakis, Argyro Repa, Michalis Tzanakakis, Christina Adamichou, Alexandra Pompieri, Giorgis Spirou, Antonios Bertsias, Eleni Kabouraki, Ioannis Tzanakis, Leda Chatzi, Prodromos Sidiropoulos, Dimitrios T Boumpas, George K Bertsias: Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece. Annals of the Rheumatic Diseases 08/2017; 76(12):annrheumdis-2017-211206., DOI:10.1136/annrheumdis-2017-211206
  16. Fanouriakis Antonis, Gergianaki Irini, Sidiropoulos Prodromos, Bertsias George, Boumpas Dimitrios: Evolving Concepts in Systemic Lupus Erythematosus. The Israel Medical Association journal: IMAJ 12/2016; 18(12).
  17. Kyle Hoedebecke, Lindsey Beaman, Joy Mugambi, Sanam Shah, Marwa Mohasseb, Cheyanne Vetter, Kim Yu, Irini Gergianaki, Emily Couvillon: Health care and social media: What patients really understand. F1000 Research 02/2017; 6:118., DOI:10.12688/f1000research.10637.1
  18. Simos P, Ktistaki G, Dimitraki G, Papastefanakis E, Kougkas N, Fanouriakis A, Gergianaki I, Bertsias G, Sidiropoulos P, Karademas EC. Cognitive deficits early in the course of rheumatoid arthritis J Clin Exp Neuropsychol. 2016 Sep;38(7):820-9.
  19. Bertsias G, Karampli E, Sidiropoulos P, Gergianaki I, Drosos A, Sakkas L, Garyfallos A, Tzioufas A, Vassilopoulos D, Tsalapaki C, Sfikakis P, Panopoulos S, Athanasakis K, Perna A, Psomali D, Kyriopoulos J, Boumpas D. Clinical and financial burden of active lupus in Greece: a nationwide study. Lupus. 2016 Apr 6. pii: 0961203316642310.
  20. Karademas EC, Ktistaki G, Dimitraki G, Papastefanakis E, Mastorodemos V, Repa A, Gergianaki I, Bertsias G, Sidiropoulos P, Simos P. Patient and partner dispositional optimism as a long-term predictor of illness representations in autoimmune diseases. J Health Psychol. 2016 Mar 8. pii: 1359105316633287.
  21. Karademas EC, Ktistaki G, Dimitraki G, Papastefanakis E, Kougkas N, Fanouriakis A, Gergianaki I, Bertsias G, Sidiropoulos P, Simos P. Adaptation to an autoimmune disorder: Does mental flexibility impact illness-related self-regulation? Psychol Health. 2016;31(3):276-91. doi: 10.1080/08870446.2015.1083568.
  22. Latsoudis, M.-F. Mashreghi, J. Gruen, H.-D. Chang, B. Stuhlmueller, A. Repa,, I. Gergianaki et al Altered Expression levels of Mir-4520A associated with familial Mediterranean fever (FMF) Ann Rheum Dis2015;74(Suppl2): 852
  23. The role of the costimulatory receptor herpes virus entry mediator (HVEM) in B-cell activation and differentiation. implications for SLE pathogenesis Seretis, A Zampoulaki, C Choulaki, I Gergianaki, P Sidiropoulos, D Boumpas, G Bertsias Ann Rheum Dis 2015;74:Suppl 1 A69-A70
  1. Gergianaki, Fanouriakis, A. Repa et al The Cretan Lupus Registy “Leto”: Prevalence, Clinical Features and environmental Factors in a genetically homogenous, mixed urban and rural, south European population Ann Rheum Dis2015;74(Suppl2): 1275
  1. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT. Arthritis Rheum. 2006 Nov;54(11):3601-11.

Δημοσιεύσεις σε περιοδικά με κριτές (εκτός Pubmed)

  1. Irini Gergianaki The Burden of Rheumatic Diseases in the Community: Raising Awareness in Primary Care Primary Care Epidemiology and Global Health. Prim Care Epidemiol Glob Health 2018(1): 10-12. (Editorial)
  2. Christina Adamichou, Dionysios Nikolopoulos, Emmanouil Papastefanakis, Eleni Kalogiannaki, Irini Gergianaki, Aggeliki Kountouri Argyro Repa, Nestor Avgoustidis, Nikolaos Kougkas, Prodromos Sidiropoulos, Antonis Fanouriakis, George Bertsias. Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus Mediterr J Rheumatol 2018;29(4):232-5
  3. Saleem-Ur-Rehman, Sm Kadri, Kaunsar Rehana, Irini Gergianaki, Dar Farooz, Afshan Abdullah: Leprosy and Hepatitis C co-infection: Epidemiological data from the Leprosarium, Srinagar, Kashmir, India. Leprosy review 06/2017; 88(2).
  4. Sm Kadri, Saleem-Ur-Rehman, Kausar Rehana, Irini Gergianaki Rising Trends of Chicken Pox Outbreaks among School Children in Kashmir, India-Suggestions for Health Policy. EC Bacteriology and Virology Research 2.5 (2017): 179-190.
  5. Kadri Sm, Saleem-Ur-Rehman, Kausar Rehana, Irini Gergianaki: Zika Virus Disease (ZIKV) Infographics, Language-tailored: Innovations and Good Good Practices in Integrated Disease Surveillance Programme Kashmir, India 2016 J Mol Pathol Epidemiol. 2017, 2:S1.

Ανακοινώσεις σε συνέδρια

  1. Γεργιανάκη Ε. Αγγελάκη Α. Αναστασάκη Μ. Βασιλάκη Ε. Καρκάνα Ν. Λιονής Χ. Μελέτη Αναγκών Υγείας και πρόταση για μια πρότυπη μονάδα πρωτοβάθμιας φροντίδας υγείας στο δήμο Αγίου Νικολάου 9ο Πανελλήνιο Συνέδριο Forum Δημόσιας Υγείας Ηράκλειο Οκτώβριος 2023 (έπαινος καλύτερης προφορικής ανακοίνωσης)
  2. Gergianaki I Anastasaki M., Papadaki S., Anastasiou F ,Koek G., Leen H., Mendive J Muris J, Lionis C. Heath literacy, illness perception and NAFLD/NASH awareness in primary care patients in Crete, Greece 14th European Public Health Conference, Virtual Event, 10-12 November 2021 (προφορική ανακοίνωση)
  3. Gergianaki I, Anastasaki M., Papadaki S, Anastasiou F. , Voltyrakis F, Sidiropoulou B., Koek G., Heyens L. JM., Mendive J. Muris J, Lionis C. Designing and implementing an evidence-based integrated multidisciplinary and patient-centered model of care for NAFLD/NASH in primary care in Europe.  93rd European General Practice Research Network (EGPRN) meeting 14 – 17 October 2021 Halle, Germany
  4. Γεργιανάκη Ε. και Τσιλιγιάννη Ι. Ρευματολογικά Νοσήματα και Χρόνια Αποφρακτική Πνευμονοπάθεια: Συστηματική Ανασκόπηση στη συνοσυρότητα και τις επιπτώσεις στις εκβάσεις των ασθενών. 26ο Ρευματολογικό Συνέδριο 2018 Αθήνα
  5. Αδαμίχου Χ. Νικολόπουλος Δ. Παπαστεφανάκης Ε. Γεργιανάκη Ε. Φανουριάκης Α., Bortoluzzi A., Καλογιαννάκη Ε., Σιδηρόπουλος Π., Μπερτσιάς Γ. Τα κριτήρια ταξινόμησης ACR/EULAR 2017 και SLICC 2012 έχουν αυξημένη ευαισθησία και ειδικότητα σε σύγκριση με τα κριτήρια ACR 1997 και ταξινομούν φαινοτυπικά διαφορετικές υποομάδες ασθενών με Συστηματικό Ερυθηματώδη Λύκο 26ο Ρευματολογικό Συνέδριο 2018 Αθήνα
  6. Christina Adamichou, Dionysios Nikolopoulos, Alessandra Bortoluzzi, Emmanouil Papastefanakis, Antonis Fanouriakis, Eleni Kalogiannaki, Irini Gergianaki, Prodromos Sidiropoulos and George Bertsias, Increased Sensitivity of the new (2017) and the 2012 SLICC as compared to the ACR 1997 Classification Criteria in early Systemic Lupus Erythematosus (SLE): The 2017 and 2012 Criteria may classify non-overlapping subgroups of patients (2018 ACR/ARHP Annual Meeting October 19-24, 2018 in Chicago, IL)
  7. Antonis Fanouriakis, Ioannis Papalopoulos, Irini Gergianaki, Giorgis Spyrou, Abdulsamet Erden, Panagiota Rapsomaniki, Maria Terizaki, Nestor Avgoustidis, Argyro Repa, Nikolaos Kougkas, George Bertsias, Dimitrios T Boumpas, Prodromos I Sidiropoulos: In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study. Clinical and experimental rheumatology Sep-Oct 2018;36(5):806-813.
  8. S Georgakis, G Papadaki, I Gergianaki, C Adamichou, S Polia, P Sidiropoulos, P Verginis, K Gkirtzimanaki, G Bertsias: O003 Characterising the role of net-derived IL-33 in SLE pathogenesis. 38th European Workshop for Rheumatology Research, 22–24 February 2018, Geneva, Switzerland; 03/2018, DOI:10.1136/annrheumdis-2018-EWRR2018.3
  9. Bertsias, N. Panousis, I.Gergianaki, Tektonidou M, Trachana M., Pamfil C., Fanouriakis A., Dermitzakis D., Boumpas D.: OP0332 The genomic architecture of systemic lupus erythematosus (SLE) by RNA-SEQ: distinct disease susceptibility, activity and severity signatures and extensive genetic effects on whole blood gene expression. Annual European Congress of Rheumatology; 07/2017, DOI:10.1136/annrheumdis-2017-eular.6802
  10. A., I.Gergianaki, G. Spyrou, N. Kougkas, A. Kountouri, N. Avgoustidis, G. Bertsias, P. Sidiropoulos: SAT0330 Lower prevalence but comparable clinical characteristics and prognosis of systemic sclerosis in Crete-Greece as compared to other European countries: a single center experience. Annual European Congress of Rheumatology; 06/2017, DOI:10.1136/annrheumdis-2017-eular.2847
  11. Irini Gergianaki, Antonios Fanouriakis, Christina Adamichou, Giorgis Spyrou, Prodromos Sidiropoulos, Dimitrios Boumpas, George Bertsias: The impact of classifying SLE patients with the SLICC-2012 versus the

Έπαινος για την προφορική ανακοίνωση στο 9ο Πανελλήνιο Συνέδριο Forum Δημόσιας Υγείας και Κοινωνικής Ιατρικής 2023 ως μέλος ερευνητικής ομάδας Καθ. κ Λιονή

Επικοινωνήστε μαζί μου

Facebook Twitter Instagram Linkedin
Irini Gergianaki 2023. All Rights Reserved.
Created with love by webdragon.gr
ΙΑΤΡΕΙΟ ΓΕΝΙΚΗΣ ΙΑΤΡΙΚΗΣ
ΙΑΤΡΕΙΟ ΠΟΡΟΣ